{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["<i>Peganum harmala</i>", "botanical", "harmine", "licorice", "medicinal mushroom", "synergen", "virucidal", "virus"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35730437", "DateCompleted": {"Year": "2022", "Month": "06", "Day": "23"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.31083/j.fbs1402012"], "Journal": {"ISSN": "1945-0524", "JournalIssue": {"Volume": "14", "Issue": "2", "PubDate": {"Year": "2022", "Month": "May", "Day": "06"}}, "Title": "Frontiers in bioscience (Scholar edition)", "ISOAbbreviation": "Front Biosci (Schol Ed)"}, "ArticleTitle": "A Possible Synergistic Herbal Solution for COVID-19.", "Pagination": {"StartPage": "12", "MedlinePgn": "12"}, "Abstract": {"AbstractText": ["The COVID-19 pandemic has provided an opportunity for repurposing of drugs, including complex, natural drugs, to meet the global need for safe and effective antiviral medicines which do not promote multidrug resistance nor inflate medical costs. The author herein describes his own repurposing of herbal tinctures, previously prepared for oncology, into a possibly synergistic, anti-COVID 41 \"herb\" formula of extracts derived from 36 different plants and medicinal mushrooms. A method of multi-sample <i>in vitro</i> testing in green monkey kidney vero cells is proposed for testing the Hypothesis that even in such a large combination, antiviral potency may be preserved, along with therapeutic synergy, smoothness, and complexity. The possibility that the formula's potency may improve with age is considered, along with a suitable method for testing it. Collaborative research inquiries are welcome."], "CopyrightInformation": "\u00a9 2022 The Author(s). Published by IMR Press."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Applied Metabolomics and Pharmacognosy (LAMP), Institute of Evolution, University of Haifa, 3498838 Haifa, Israel."}], "LastName": "Lansky", "ForeName": "Ephraim Shmaya", "Initials": "ES"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Singapore", "MedlineTA": "Front Biosci (Schol Ed)", "NlmUniqueID": "101485241", "ISSNLinking": "1945-0516"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Chlorocebus aethiops"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Pandemics"}, {"QualifierName": [], "DescriptorName": "Peganum"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Seeds"}, {"QualifierName": [], "DescriptorName": "Vero Cells"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The author will provide the composition gratis to fellow researchers via academic collaborations for furthering experimental or investigations. The author declares no legal, financial, or institutional conflicts of interest."}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2022", "Month": "3", "Day": "1"}, {"Year": "2022", "Month": "3", "Day": "30"}, {"Year": "2022", "Month": "4", "Day": "7"}, {"Year": "2022", "Month": "6", "Day": "22", "Hour": "5", "Minute": "5"}, {"Year": "2022", "Month": "6", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "24", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35730437", "10.31083/j.fbs1402012", "S1945-0516(22)00058-2"]}}], "PubmedBookArticle": []}